Literature DB >> 9000424

The peptide "FRCRCFa", dialysed intracellularly, inhibits the Na/Ca exchange in rabbit ventricular myocytes with high affinity.

I A Hobai1, D Khananshvili, A J Levi.   

Abstract

We investigated the effect in rabbit ventricular myocytes of "FRCRCFa", a newly developed peptide inhibitor of the Na/Ca exchange. Myocytes were whole-cell patch clamped and experiments were carried out at 36 degrees C. The Na/Ca exchange was measured selectively, by blocking interfering ion channel currents and the Na/K pump, as the membrane current which could be inhibited by 5 mM nickel (Ni; a known blocker of the Na/Ca exchange). Increasing concentrations of FRCRCFa dialysed into the cell from the patch-pipette inhibited the Na/Ca exchange current. The dose/response curve could be fitted by a function for co-operative ligand binding, which predicted a KD for FRCRCFa-mediated inhibition of 22.7 +/- 3.7 nM, with a Hill coefficient of 0.61 +/- 0.06. Pipette FRCRCFa concentrations of 1 micro;M and above were sufficient to cause complete inhibition of Na/Ca exchange current. The inhibitory effect of FRCRCFa was independent of membrane potential and relatively selective: 10 micro;M FRCRCFa dialysed into the cell had no effect on the L-type Ca current and delayed rectifier and inward rectifier K currents. Thus FRCRCFa appears to be a potent and relatively selective inhibitor of the Na/Ca exchange in intact cardiac myocytes, and may be of value for studies of the Na/Ca exchange.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000424     DOI: 10.1007/s004240050300

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  9 in total

Review 1.  Mechanisms underlying the cardiac pacemaker: the role of SK4 calcium-activated potassium channels.

Authors:  David Weisbrod; Shiraz Haron Khun; Hanna Bueno; Asher Peretz; Bernard Attali
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 2.  Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions.

Authors:  Daniel Khananshvili
Journal:  Pflugers Arch       Date:  2013-11-27       Impact factor: 3.657

3.  Direct Loading of the purified endogenous inhibitor into the cytoplasm of patched cardiomyocytes blocks the ion currents and calcium transport through the NCX1 protein.

Authors:  Liron Boyman; Reuben Hiller; W Jonathan Lederer; Daniel Khananshvili
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

4.  SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells.

Authors:  David Weisbrod; Asher Peretz; Anna Ziskind; Nataly Menaker; Shimrit Oz; Lili Barad; Sivan Eliyahu; Joseph Itskovitz-Eldor; Nathan Dascal; Daniel Khananshvili; Ofer Binah; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

5.  Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs.

Authors:  Norbert Jost; László Virág; Philippe Comtois; Balázs Ordög; Viktória Szuts; György Seprényi; Miklós Bitay; Zsófia Kohajda; István Koncz; Norbert Nagy; Tamás Szél; János Magyar; Mária Kovács; László G Puskás; Csaba Lengyel; Erich Wettwer; Ursula Ravens; Péter P Nánási; Julius Gy Papp; András Varró; Stanley Nattel
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

6.  ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart.

Authors:  N Jost; N Nagy; C Corici; Z Kohajda; A Horváth; K Acsai; P Biliczki; J Levijoki; P Pollesello; T Koskelainen; L Otsomaa; A Tóth; J Gy Papp; A Varró; L Virág
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

7.  Proton-modulated interactions of ions with transport sites of prokaryotic and eukaryotic NCX prototypes.

Authors:  Bosmat Refaeli; Stephanie Liu; Reuben Hiller; Moshe Giladi; Carlos R Baiz; Daniel Khananshvili
Journal:  Cell Calcium       Date:  2021-09-20       Impact factor: 6.817

8.  The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.

Authors:  Zsófia Kohajda; Nikolett Farkas-Morvay; Norbert Jost; Norbert Nagy; Amir Geramipour; András Horváth; Richárd S Varga; Tibor Hornyik; Claudia Corici; Károly Acsai; Balázs Horváth; János Prorok; Balázs Ördög; Szilvia Déri; Dániel Tóth; Jouko Levijoki; Piero Pollesello; Tuula Koskelainen; Leena Otsomaa; András Tóth; István Baczkó; István Leprán; Péter P Nánási; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

9.  Discovery and characterization of ORM-11372, a novel inhibitor of the sodium-calcium exchanger with positive inotropic activity.

Authors:  Leena Otsomaa; Jouko Levijoki; Gerd Wohlfahrt; Hugh Chapman; Ari-Pekka Koivisto; Kaisa Syrjänen; Tuula Koskelainen; Saara-Elisa Peltokorpi; Piet Finckenberg; Aira Heikkilä; Najah Abi-Gerges; Andre Ghetti; Paul E Miller; Guy Page; Eero Mervaala; Norbert Nagy; Zsófia Kohajda; Norbert Jost; László Virág; András Varró; Julius Gy Papp
Journal:  Br J Pharmacol       Date:  2020-11-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.